Here are six notes:
1. SpineGuard reported third quarter revenue of €1.7 million, representing a 2 percent increase compared to the third quarter in 2015.
2. The company’s U.S. revenue decreased by 3 percent, and the rest of the world revenue increased by 29 percent in the third quarter.
3. For the first nine months of 2016, SpineGuard reported revenue of €5.31 million, reflecting a 15 percent increase compared to the same time period in 2015.
4. The U.S. revenue growth for the first nine months of the year was 15 percent.
5. SpineGuard sold 6,324 PediGuard units in the first nine months of 2016, up from 5,580 units in the same time period in 2015.
6. The company sold 3,581 units in the United States in the first nine months of 2016, accounting for 57 percent of total units sold.
More articles on devices:
North America dominates expansive medical implants market — 6 takeaways
North America, Europe lead orthopedic imaging market through 2026: 5 notes
Quantum computing, robotics & more — Which technologies will change healthcare by 2025?
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
